drugset

drugset / Trial / NCT00885625

7-valent Pneumococcal Conjugated Vaccination

NCT00885625 ↗

Phase 4 Unknown 350 enrolled National Taiwan University Hospital National Science and Technology Council, Taiwan · collab

Non-randomizedParallel-groupOpen-labelPrevention

Summary

Hypothesis: the efficacy of 2 doses 7-valent PCV is equivalent to 1 dose 7-valent PCV.

Timeline

Start: 2009-03
Primary completion: 2010-04
Completion: 2010-04

Publications

Lu CL, Chang SY, Chuang YC, Liu WC, Su CT, Su YC, Chang SF, Hung CC. Revaccination with 7-valent pneumococcal conjugate vaccine elicits better serologic response than 23-valent pneumococcal polysaccharide vaccine in HIV-infected adult patients who have undergone primary vaccination with 23-valent pneumococcal polysaccharide vaccine in the era of combination antiretroviral therapy. Vaccine. 2014 Feb 19;32(9):1031-5. doi: 10.1016/j.vaccine.2014.01.009. Epub 2014 Jan 15.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	7-valent pneumococcal conjugated vaccine	Vaccine	0.5 ml	Intramuscular

Indications